These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 3989296

  • 1. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
    Dorshkind K, Pollack SB, Bosma MJ, Phillips RA.
    J Immunol; 1985 Jun; 134(6):3798-801. PubMed ID: 3989296
    [Abstract] [Full Text] [Related]

  • 2. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA, Pedersen KF, Welsh RM.
    J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814
    [Abstract] [Full Text] [Related]

  • 3. Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency.
    Garni-Wagner BA, Witte PL, Tutt MM, Kuziel WA, Tucker PW, Bennett M, Kumar V.
    J Immunol; 1990 Feb 01; 144(3):796-803. PubMed ID: 2136898
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adherent lymphokine-activated natural killer cells in normal and severe combined immunodeficiency mice: large granular lymphocytes with natural killer cell phenotype and high cytolytic activity.
    Chang HL, Zaroukian MH, Morrison MH, Esselman WJ.
    Nat Immun Cell Growth Regul; 1989 Jun 01; 8(2):89-99. PubMed ID: 2788243
    [Abstract] [Full Text] [Related]

  • 8. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
    Suzuki S, Suzuki R, Onta T, Kumagai K.
    Nat Immun Cell Growth Regul; 1986 Jun 01; 5(2):75-89. PubMed ID: 3487716
    [Abstract] [Full Text] [Related]

  • 9. Effector and precursor phenotypes of lymphokine-activated killer cells in mice with severe combined immunodeficiency (scid) and athymic (nude) mice.
    Hasui M, Saikawa Y, Miura M, Takano N, Ueno Y, Yachie A, Miyawaki T, Taniguchi N.
    Cell Immunol; 1989 Apr 15; 120(1):230-9. PubMed ID: 2784720
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL, Chourmouzis E, Sigindere J, MacIntyre JP, Capetola RJ, Lau CY.
    Cell Immunol; 1993 Apr 01; 147(2):302-12. PubMed ID: 8453674
    [Abstract] [Full Text] [Related]

  • 12. In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states.
    Butler LD, Browne CP, Layman NK, Riedl P, Tang J, Marder P, DeLong D, Manetta J, Bobbitt L, Strnad J.
    Cancer Res; 1988 Nov 01; 48(21):6081-9. PubMed ID: 3048654
    [Abstract] [Full Text] [Related]

  • 13. Characterization of natural killer activity in sponge matrix allografts.
    Hoffman RA, Ascher NL, Jordan ML, Migliori RJ, Simmons RL.
    J Immunol; 1988 Mar 01; 140(5):1702-10. PubMed ID: 3257981
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of natural killer activity by calcitonin gene-related peptide.
    Umeda Y, Arisawa M.
    Immunopharmacol Immunotoxicol; 1989 Mar 01; 11(2-3):309-20. PubMed ID: 2559931
    [Abstract] [Full Text] [Related]

  • 15. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
    Stein-Streilein J, Bennett M, Mann D, Kumar V.
    J Immunol; 1983 Dec 01; 131(6):2699-704. PubMed ID: 6644021
    [Abstract] [Full Text] [Related]

  • 16. Natural killer (NK) cells and graft-versus-host disease (GVHD): no correlation between the NK cell levels and GVHD in the murine P----F1 model.
    Varkila K, Hurme M.
    Immunology; 1985 Jan 01; 54(1):121-6. PubMed ID: 3972429
    [Abstract] [Full Text] [Related]

  • 17. T cell receptor genes do not rearrange or express functional transcripts in natural killer cells of scid mice.
    Tutt MM, Schuler W, Kuziel WA, Tucker PW, Bennett M, Bosma MJ, Kumar V.
    J Immunol; 1987 Apr 01; 138(7):2338-44. PubMed ID: 3559207
    [Abstract] [Full Text] [Related]

  • 18. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 01; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 19. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
    Kaminsky SG, Nakamura I, Cudkowicz G.
    J Immunol; 1983 Apr 01; 130(4):1980-4. PubMed ID: 6833756
    [Abstract] [Full Text] [Related]

  • 20. Natural killer activity of gut mucosal lymphoid cells in mice.
    Tagliabue A, Luini W, Soldateschi D, Boraschi D.
    Eur J Immunol; 1981 Nov 01; 11(11):919-22. PubMed ID: 7327195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.